Alert: There is an updated RSS feed for Neurology® Clinical Practice: http://www.aan.com/rss/index.cfm?event=feed.items&channel=1. The Neurology journals have combined all feeds into a central location to better serve subscribers. Neurology® Clinical Practice, an official journal of the American Academy of Neurology, brings the neurologist timely updates of peer-reviewed clinical neurology material, along with helpful analyses of office-based and health policy issues.
http://www.aan.com/rss/?event=feed&channel=22
February 2015 Issue
John Corboy, Editor of Neurology: Clinical Practice introduces highlights from the February 2015 issue. Dr. Corboy then interviews Drs. Joseph Lockhart and Saty Satya-Murti about a paper titled "Symptom exaggeration and symptom validity testing in persons with medically unexplained neurologic presentations."
J. Corboy served as a Section Editor for Neurology Today and serves as editor of Neurology: Clinical Practice; serves on the speakers' bureau for ProCE; receives/received research support from Genentech, Novartis, Biogen IDEC, Teva, Eli Lilly, Orasi Medical, NIH, Juvenile Diabetes Research Foundation, and National MS Society; and has participated in medico-legal cases. J.J. Lockhart has received funding for travel from SAMHSA/NIDA for training and developing Veterans' Treatment Courts and serves on the editorial advisory board for Open Access Journal of Forensic Psychology.S. Satya-Murti has participated in telephone consultations and/or in-person Medical Advisory Board meetings for Evidera (formerly a division of United BioSource Corporation [UBC]), Medical Market Strategists, Pfizer; Simon-Kucher Consultants, Stratas Consultants, AstraZeneca, Avalere LLC, Covidien, Michael J. Fox Foundation, Foley Hoag and Baxter, and 1798 Consultants; and has received funding for travel from Evidera (formerly a division of UBC), Pfizer, Medical Market Strategists, AstraZeneca, Covidien, Avalere LLC, Baxter, and Michael J. Fox Foundation; serves on the editorial board of Neurology: Clinical Practice; and served as panelist and later (2010-2011) Vice-Chair CMS-Medcac (Medicare Evidence Development and Coverage Advisory Committee). For the duration of the Medcac meeting, usually 1-2 days, he was considered a Special Government Employee (SGE).